ClinicalTrials.Veeva

Menu

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Otsuka logo

Otsuka

Status and phase

Completed
Phase 3

Conditions

Bipolar I Disorder

Treatments

Drug: aripiprazole

Study type

Interventional

Funder types

Industry

Identifiers

NCT00046384
CN138-077

Details and patient eligibility

About

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Patients with acute symptoms of Bipolar Disorder

Trial contacts and locations

14

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems